1
Enhertu received accelerated approval on Thursday to treat adults with unresectable or metastatic non-tiny cell lung cancer whose tumors have activating HER2 mutations, and who have already received a prior systemic therapy.

Comments

Who Upvoted this Story

What is Plikli?

Plikli is an open source content management system that lets you easily create your own user-powered website.

Latest Comments
Statistics